Cargando…

Equine glucagon-like peptide-1 receptor physiology

BACKGROUND: Equine metabolic syndrome (EMS) is associated with insulin dysregulation, which often manifests as post-prandial hyperinsulinemia. Circulating concentrations of the incretin hormone, glucagon-like peptide-1 (GLP-1) correlate with an increased insulin response to carbohydrate intake in an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kheder, Murad H., Bailey, Simon R., Dudley, Kevin J., Sillence, Martin N., de Laat, Melody A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2018
Materias:	Veterinary Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793710/ https://www.ncbi.nlm.nih.gov/pubmed/29404215 http://dx.doi.org/10.7717/peerj.4316

Ejemplares similares

Sweet taste receptor inhibitors: Potential treatment for equine insulin dysregulation
por: de Laat, Melody Anne, et al.
Publicado: (2018)

A “modified Obel” method for the severity scoring of (endocrinopathic) equine laminitis
por: Meier, Alexandra, et al.
Publicado: (2019)

Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis
por: de Laat, Melody A., et al.
Publicado: (2019)

An investigation of the equine epidermal growth factor system during hyperinsulinemic laminitis
por: de Laat, Melody A., et al.
Publicado: (2019)

Demographic, morphologic, hormonal and metabolic factors associated with the rate of improvement from equine hyperinsulinaemia-associated laminitis
por: Sillence, Martin, et al.
Publicado: (2022)

Differential Proteomic Expression of Equine Cardiac and Lamellar Tissue During Insulin-Induced Laminitis
por: Campolo, Allison, et al.
Publicado: (2020)

Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
por: Willard, Francis S., et al.
Publicado: (2012)

Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans
por: Welch, Andrew A., et al.
Publicado: (2023)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
por: Paternoster, Silvano, et al.
Publicado: (2018)

Immunohistochemistry for the detection of neural and inflammatory cells in equine brain tissue
por: Delcambre, Gretchen H., et al.
Publicado: (2016)

A simple method of equine limb force vector analysis and its potential applications
por: Hobbs, Sarah Jane, et al.
Publicado: (2018)

Beneficial Effects of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Asthma: A Literature Review
por: Kanwar, Meeta K, et al.
Publicado: (2022)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
por: Pocai, Alessandro, et al.
Publicado: (2009)

Investigating the Glucagon Receptor and Glucagon-Like Peptide 1 Receptor Activity of Oxyntomodulin-Like Analogues in Male Wistar Rats
por: Price, Samantha L., et al.
Publicado: (2015)

Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses
por: Rahnama, Samira, et al.
Publicado: (2020)

A Review of Equine Sleep: Implications for Equine Welfare
por: Greening, Linda, et al.
Publicado: (2022)

Characterization of Nuclear Progesterone Receptor Isoforms in the Term Equine Placenta
por: Nagy, Ahmed M., et al.
Publicado: (2021)

Simultaneous detection and quantification of six equine cytokines in plasma using a fluorescent microsphere immunoassay (FMIA)
por: Hall, Sarah A., et al.
Publicado: (2015)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
por: Murakami, Takaaki, et al.
Publicado: (2020)

The gut hormone glucagon-like peptide-1 produced in brain: is this physiologically relevant?
por: Trapp, Stefan, et al.
Publicado: (2013)

Adolescents' Affective and Physiological Regulation Shape Negative Behavior During Challenging Equine Assisted Learning Activities
por: Pendry, Patricia, et al.
Publicado: (2018)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
por: Kang, Yu Mi, et al.
Publicado: (2016)

Glucagon‐like peptide‐1 receptor expression in the human eye
por: Hebsgaard, Josephine B., et al.
Publicado: (2018)

How glucagon-like peptide 1 receptor agonists work
por: Andreasen, Christine Rode, et al.
Publicado: (2021)

Glucagon-like Peptide-1 Receptor Analogues for the Treatment of Obesity
por: Williams, David M, et al.
Publicado: (2022)

Stability of glucagon-like peptide 1 and glucagon in human plasma
por: Wewer Albrechtsen, Nicolai J, et al.
Publicado: (2015)

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
por: Ammann, Markus, et al.
Publicado: (2023)

Survey of equine veterinarians regarding primary equine back pain in the United States
por: Marshall-Gibson, Marianne E., et al.
Publicado: (2023)

Developmental Results of a Vaccine against Salmonella-Induced Equine Abortion
por: Neustroev, M. P., et al.
Publicado: (2020)

Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor–Positive Lesions
por: Boss, Marti, et al.
Publicado: (2020)

The cresty neck score is an independent predictor of insulin dysregulation in ponies
por: Fitzgerald, Danielle M., et al.
Publicado: (2019)

Gene therapy approaches for equine osteoarthritis
por: Thampi, Parvathy, et al.
Publicado: (2022)

Equine Umbilical Cord Serum Composition and Its Healing Effects in Equine Corneal Ulceration
por: Peyrecave-Capo, Xavier, et al.
Publicado: (2022)

Physiological and pharmacological actions of glucagon like peptide-1 (GLP-1) in domestic animals
por: Model, Jorge F A, et al.
Publicado: (2022)

Glucagon-Like Peptide-1 and Diabetes
por: Monami, Matteo
Publicado: (2011)

Patient preferences for glucagon-like peptide 1 receptor–agonist treatment attributes
por: Thieu, Vivian T, et al.
Publicado: (2019)

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate
por: Lorenz, Martin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_friu31jv5agjmfa9qg1jr1q2sl